Why is Medicamen Biotec falling/rising?

As of 25-Aug, Medicamen Biotech Ltd's stock price is currently at 350.00, reflecting a decrease of 1.0 (-0.28%). The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 3.02% during this period. Additionally, it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock is also close to its 52-week low, being only 2.07% away from Rs 342.75. Over the past week, the stock has declined by 1.46%, and it has experienced significant losses year-to-date, down 31.27%, compared to a modest gain of 4.48% in the benchmark Sensex.
In the broader market context, while the Sensex has shown a positive return of 0.45% over the past week, Medicamen Biotech's performance has been notably poor, with a 1W return of -1.46%. This underperformance is further highlighted by the stock's significant declines over longer periods, including a 66.88% drop over the last three years. Despite a rise in investor participation, with delivery volume increasing by 36.41% against the 5-day average, the overall sentiment appears negative, contributing to the stock's downward trajectory. The absence of any positive factors in the dashboard suggests that there are no current catalysts to reverse this trend.